Efficacy and safety of cisplatin for the management of adult patients with oral cancer A protocol for systematic review

被引：2

作者：

Feng, Yao ^{[1
]}

Yang, Dian-song ^{[1
]}

Tang, Hai-bo ^{[2
]}

Ding, Yuan-sheng ^{[3
]}

Li, Xiao-guang ^{[3
]}

机构：

[1] Jiamusi Univ, Affiliated Hosp 2, Dent Pulp Dis Dept, Unit 1, 566 Changanxi Rd, Jiamusi 154002, Peoples R China

[2] Jiamusi Univ, Affiliated Hosp 2, Dept Radiat, Jiamusi, Peoples R China

[3] Jiamusi Univ, Affiliated Hosp 2, Dept Orthodont, Jiamusi, Peoples R China

来源：

MEDICINE | 2019年 / 98卷 / 51期

关键词：

cisplatin; efficacy; oral cancer; safety; CHEMOTHERAPY; 5-FLUOROURACIL; DOCETAXEL; INFUSION;

D O I：

10.1097/MD.0000000000018210

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Cisplatin is often used for the treatment of oral cancer (OC). However, there are inconsistent results. Thus, this study plans to systematically assess the clinical efficacy and safety of cisplatin for adult patients with OC. Methods: We will search for PUBMED, EMBASE, Cochrane Library, AMED, Cumulative Index to Nursing and Allied Health Literature, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure. All of them will be searched from the construction of each database up to the present with no restrictions of language and publication status. The data analysis will be conducted using RevMan 5.3 software to assess the efficacy and safety of cisplatin for adult patients with OC. Results: This study will summarize the most recent high-quality evidence and will provide helpful information about the efficacy and safety of cisplatin for adult patients with OC. Conclusion: The findings of this study will provide convinced evidence of cisplatin for adult patients with OC, and provide recommendations for clinical practice.

引用

页数：3

共 22 条

[11]

Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]

[12] Expert Consensus on the Detection and Screening of Oral Cancer and Precancer [J].

Kao, Shou Yen ;

Mao, Li ;

Jian, Xin Chun ;

Rajan, Gunaseelan ;

Yu, Guang Yan .

CHINESE JOURNAL OF DENTAL RESEARCH, 2015, 18 (02) :79-83

[13] Chemoembolization using cisplatin crystals as neoadjuvant treatment of oral cancer [J].

Kovács, AF .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2005, 20 (03) :267-279

[14] Exciting new advances in oral cancer diagnosis: avenues to early detection [J].

Mehrotra, Ravi ;

Gupta, Dwijendra K. .

HEAD & NECK ONCOLOGY, 2011, 3

[15]

Patton D W, 1994, Dent Update, V21, P231

[16]

Rhodus Nelson L, 2017, Northwest Dent, V96, P21

[17]

Rivera C, 2015, INT J CLIN EXP PATHO, V8, P11884

[18]

Rohde S, 2005, AM J NEURORADIOL, V26, P1804

[19] Concurrent chemoradiotherapy with intravenous cisplatin and docetaxel for advanced oral cancer [J].

Sato, Kotaro ;

Hayashi, Yasushi ;

Watanabe, Kazuyo ;

Yoshimi, Ryoko ;

Hibi, Hideharu .

NAGOYA JOURNAL OF MEDICAL SCIENCE, 2019, 81 (03) :407-414

[20] Elevated growth differentiating factor 15 expression predicts long-term benefit of docetaxel, cisplatin and 5-fluorouracil induction chemotherapy in patients with oral cancer [J].

Tang, Xiao ;

Hu, Yong-Jie ;

Ju, Wu-Tong ;

Fu, Yong ;

Sun, Wen-Wen ;

Liu, Ying ;

Tan, Yi-Ran ;

Wang, Li-Zhen ;

Li, Jiang ;

Tu, Yao-Yao ;

Zhang, Chen-Ping ;

Zhang, Zhi-Yuan ;

Zhong, Lai-Ping .

ONCOLOGY LETTERS, 2018, 15 (05) :8118-8124

← 1 2 3 →